Omslagafbeelding van de show Ozempic and Your Brain — What the Science Says

Ozempic and Your Brain — What the Science Says

Podcast door Inception Point AI

Engels

Technologie en Wetenschap

Tijdelijke aanbieding

2 maanden voor € 1

Daarna € 9,99 / maandElk moment opzegbaar.

  • 20 uur luisterboeken / maand
  • Podcasts die je alleen op Podimo hoort
  • Gratis podcasts
Begin hier

Over Ozempic and Your Brain — What the Science Says

Dr. Ben Synth explores the cutting-edge neuroscience of GLP-1 drugs like Ozempic, revealing how these medications affect memory, mood, and the brain's reward system. From Alzheimer's prevention to addiction pathways, discover what happens when a weight-loss drug rewires your brain. For more content like this, visit QuietPlease.ai This content was created in partnership and with the help of Artificial Intelligence AI.

Alle afleveringen

2 afleveringen

aflevering Ozempic and Your Brain — What the Science Says - Mood on the Scale: The Serotonin Puzzle artwork

Ozempic and Your Brain — What the Science Says - Mood on the Scale: The Serotonin Puzzle

Ben Synth examines how semaglutide affects mental health, exploring evidence that shows the diabetes and weight-loss drug may improve mood for some while triggering depression in others. The episode covers animal studies, massive patient databases, clinical trials, and the complex relationship between GLP-1 receptors, serotonin systems, and individual brain chemistry that could explain these contradictory outcomes. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7 apr 2026 - 23 min
aflevering Ozempic and Your Brain — What the Science Says - The Alzheimer's Question artwork

Ozempic and Your Brain — What the Science Says - The Alzheimer's Question

Dr. Ben Synth examines groundbreaking research linking semaglutide to potential Alzheimer's protection, analyzing studies of over 100 million patients showing 40-70% risk reduction. He explores the biological mechanisms, discusses critical caveats about observational data versus randomized trials, and explains why GLP-1 receptors in the brain matter for memory and cognition. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7 apr 2026 - 24 min
Meld je aan om te luisteren
Super app. Onthoud waar je bent gebleven en wat je interesses zijn. Heel veel keuze!
Super app. Onthoud waar je bent gebleven en wat je interesses zijn. Heel veel keuze!
Makkelijk in gebruik!
App ziet er mooi uit, navigatie is even wennen maar overzichtelijk.

Kies je abonnement

Meest populair

Tijdelijke aanbieding

Premium

20 uur aan luisterboeken

  • Podcasts die je alleen op Podimo hoort

  • Geen advertenties in Podimo shows

  • Elk moment opzegbaar

2 maanden voor € 1
Daarna € 9,99 / maand

Begin hier

Premium Plus

Onbeperkt luisterboeken

  • Podcasts die je alleen op Podimo hoort

  • Geen advertenties in Podimo shows

  • Elk moment opzegbaar

Probeer 7 dagen gratis
Daarna € 13,99 / maand

Probeer gratis

Alleen bij Podimo

Populaire luisterboeken

Veelgestelde vragen

Meer vragen & antwoorden
Begin hier

2 maanden voor € 1. Daarna € 9,99 / maand. Elk moment opzegbaar.